Small Hotels
Market Cap
₹19,847 ₹19,847 Cr.
P/E
42.86
PEG
1.80
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

Base-case revenue growth is anchored by same-store RevPAR expansion (~10% CAGR) and a 9-hotel pipeline, but Rs.425 Cr of FY30 EBITDA relies on unidentified acquisitions—the least verifiable bridge component.

Bull case triggers: all pipeline hotels and BKC open by H1 FY29, Dubai rebranding accelerated, and new acquisitions deliver over Rs.500 Cr EBITDA, pushing revenue CAGR above 20%.

Bear case triggers: pipeline delays of >6 months across multiple hotels, international inbound staying below 40% of guest mix, and acquisition shortfall, compressing revenue CAGR to single digits.

Get your Reports on Demand
Get detailed, analyst-grade reports with actionable insights to make informed investment decisions.
  Flat 20% OFF
 for Tijori Premium Users
  Flat 20% OFF  for Tijori Premium Users
5Y Revenue & EBITDA Estimates
KEY TRIGGERS TO WATCH
  • Base-case revenue growth is anchored by same-store RevPAR expansion (~10% CAGR) and a 9-hotel pipeline, but Rs.425 Cr of FY30 EBITDA relies on unidentified acquisitions—the least verifiable bridge component.
  • Bull case triggers: all pipeline hotels and BKC open by H1 FY29, Dubai rebranding accelerated, and new acquisitions deliver over Rs.500 Cr EBITDA, pushing revenue CAGR above 20%.
  • Bear case triggers: pipeline delays of >6 months across multiple hotels, international inbound staying below 40% of guest mix, and acquisition shortfall, compressing revenue CAGR to single digits.
Bear : 0.4% CAGR • ₹186 Cr
Base: 5.4% CAGR • ₹236 Cr
Bull: 9.5% CAGR • ₹286 Cr
Buy Report $5
Management Credibility Report
TRACK RECORD
  • Management delivers operational and balance-sheet commitments with precision—EBITDA growth, F&B targets, NPS, and credit rating all met or exceeded.
  • Misses cluster entirely on forward-looking launch timelines; greenfield and rebranding projects consistently need 6-12 month slippage allowances.
  • Quarterly RevPAR guidance during geopolitical stress proved over-optimistic, exposing a pattern of inflated near-term external assumptions.
Met : 13
Progress: 2
Missed : 4
Buy Report $5
WORST-CASE SCENARIO
  • Overall clean forensic profile with strong cash conversion (OCF/EBITDA 95.5%) and dramatic IPO-led deleveraging.
  • One medium-risk governance item: share count expanded from 20.2 Mn to 334.0 Mn due to pre-IPO restructuring, a one-time event not serial dilution, but it compressed EPS relative to PAT growth.
  • Most severe tail risk is promoter pledge invocation on 55.91% of shares under Brookfield’s $500M facility, though company-level financials remain robust.
High Risk : 0
Medium Risk : 1
Low Risk : 16
Buy Report $5
Powered By
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material